Collectively, these findings demonstrate that USP20 promotes EMT, migration, drug resistance and cancer stemness through upregulating CTSL expression, highlighting its potential as a therapeutic target in HNSCC. Here, USP20 is linked to head and neck squamous cell carcinoma.